---
figid: PMC3564524__210fig10
figtitle: Novel signaling pathways involved in apo(a)-mediated effects on vascular
  endothelial cells
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Capra hircus
- Equus asinus
- Armoracia rusticana
- Nicotiana tabacum
- Candida dubliniensis
- Homo sapiens
- Mus musculus
organisms_ner:
- Bos taurus
- Equus asinus
- Homo sapiens
- Mus musculus
- Capra hircus
- Oryctolagus cuniculus
- Danio rerio
pmcid: PMC3564524
filename: 210fig10.jpg
figlink: /pmc/articles/PMC3564524/figure/F10/
number: F10
caption: Novel signaling pathways involved in apo(a)-mediated effects on vascular
  endothelial cells. Apo(a), through its strong LBS in KIV10, binds to a putative
  receptor (possibly a complex of CD36 and TLR2), resulting in activation of a Src-
  and Rho/Rho kinase–dependent pathway to increased VE-cadherin/β-catenin complex
  dissociation, leading to an increase in vascular permeability in cultured EC. Apo(a)
  also induces a PI3K/Akt/GSK-3β signaling pathway, independent of the Rho/Rho kinase
  pathway, to increase β-catenin nuclear translocation, and hence COX-2 expression,
  and PGE2 secretion. Furthermore, apo(a) mediates loss of cell–cell contact and stimulates
  β-catenin translocation by disrupting the VE-cadherin/β-catenin complex through
  inhibition of PTEN.
papertitle: 'Apolipoprotein(a) stimulates nuclear translocation of β-catenin: a novel
  pathogenic mechanism for lipoprotein(a).'
reftext: Taewoo Cho, et al. Mol Biol Cell. 2013 Feb 1;24(3):210-221.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8956152
figid_alias: PMC3564524__F10
figtype: Figure
redirect_from: /figures/PMC3564524__F10
ndex: 193046ab-dee6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3564524__210fig10.html
  '@type': Dataset
  description: Novel signaling pathways involved in apo(a)-mediated effects on vascular
    endothelial cells. Apo(a), through its strong LBS in KIV10, binds to a putative
    receptor (possibly a complex of CD36 and TLR2), resulting in activation of a Src-
    and Rho/Rho kinase–dependent pathway to increased VE-cadherin/β-catenin complex
    dissociation, leading to an increase in vascular permeability in cultured EC.
    Apo(a) also induces a PI3K/Akt/GSK-3β signaling pathway, independent of the Rho/Rho
    kinase pathway, to increase β-catenin nuclear translocation, and hence COX-2 expression,
    and PGE2 secretion. Furthermore, apo(a) mediates loss of cell–cell contact and
    stimulates β-catenin translocation by disrupting the VE-cadherin/β-catenin complex
    through inhibition of PTEN.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLG
  - CD36
  - TLR2
  - RHO
  - GRK1
  - PIK3CB
  - SRC
  - PTEN
  - AKT1
  - CDH5
  - GSK3B
  - CTNNB1
  - COX2
  - LPA
  - APOA1
  - APOA2
  - APOA4
  - APOA5
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - PIK3CA
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - FGR
  - FYN
  - YES1
  - AKT2
  - AKT3
  - PTGS2
  - Cd36
  - Scarb1
  - Tlr2
  - Rho
  - Rhod
  - Ea2
  - Grk1
  - Pik3r1
  - Src
  - Pten
  - Akt1
  - Cdh5
  - Gsk3b
  - Ctnnb1
  - Ptgs2
  - CTNND1
  - apoa1a
  - cd36
  - tlr2
  - rho
  - rnd2
  - src
  - ptenb
  - cdh5
  - gsk3ba
  - ctnnb1
  - Cancer
---
